Please provide your email address to receive an email when new articles are posted on . Device-based therapy may be necessary for certain patients with NYHA class II/III heart failure with reduced ...

The development of a successful gene therapy for RPE65-associated inherited retinal disease is a major breakthrough, but it also prompts difficult questions about which patients are good candidates ...

Researchers have developed a new computational approach that uncovers possible drugs for specific cellular targets for ...

Treatment Algorithms for Hormone Receptor-Positive Advanced Breast Cancer: Applying the Results from Recent Clinical Trials into Daily Practice—Insights, Limitations, and Moving Forward Treating ...

Dr Haumschild leads a discussion surrounding the latest advancements in treatment algorithms for myelodysplastic syndrome. The discussion centered on diverse treatment strategies for myelodysplastic ...

Hormone receptor-positive (HR+) breast cancer is the most prevalent subtype of breast cancer in both early- and advanced-stage disease. Moreover, the treatment of HR+ breast cancer has had the ...

Researchers at North Carolina State University have developed a mathematical model for computing radiation therapy treatments that could substantially reduce patient side effects while delivering the ...

A groundbreaking collaboration provides useful advice on a clinically challenging problem. Depression is common in women during the childbearing years, and psychiatrists and obstetricians alike can ...

Please provide your email address to receive an email when new articles are posted on . An algorithm is a set of instructions for solving a problem or accomplishing a task. One common example of an ...

DelveInsight’s, “Cell and Gene Therapy in Parkinson’s Disease - Pipeline Insight, 2025” report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in Cell and Gene Therapy in ...

Surgery precedes biologics but comes after saline irrigations and topical intranasal corticosteroids in a new treatment algorithm for US clinicians treating patients who have chronic rhinosinusitis ...